See how a robotic-assisted innovation could help with knee-replacement surgery
Over three million people have knee-replacement surgery each year. The VELYSTM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.
The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.
Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.
Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.